Share Price | DSM-Firmenich AG Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

653.1 k

Shareholding (Dec 2025)

FII

0.23%

Held by 3 FIIs

DII

99.77%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor Management Efficiency with a low ROE of 2.20%

The company has been able to generate a Return on Equity (avg) of 2.20% signifying low profitability per unit of shareholders funds
INTEREST(HY) At EUR 74 MM has Grown at 60.87%
RAW MATERIAL COST(Y) Grown by 7.21% (YoY)

With ROE of 2.54%, it has a Very Expensive valuation with a 0.83 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 15,121 Million ()

P/E

33.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.16

Return on Equity

2.54%

Price to Book

0.83

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-11.99%

6 Months

-15.71%

1 Year

-34.17%

2 Years

-42.98%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

DSM-Firmenich AG for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

12.53%

EBIT Growth (5y)

65.71%

EBIT to Interest (avg)

7.05

Debt to EBITDA (avg)

0.84

Net Debt to Equity (avg)

0.09

Sales to Capital Employed (avg)

0.37

Tax Ratio

34.43%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.23%

ROCE (avg)

3.39%

ROE (avg)

2.20%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.83

EV to EBIT

22.36

EV to EBITDA

10.60

EV to Capital Employed

0.85

EV to Sales

2.00

PEG Ratio

1.11

Dividend Yield

ROCE (Latest)

3.81%

ROE (Latest)

2.54%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Bearish

OBV

Mildly Bullish

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 3 Foreign Institutions (0.23%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by DSM-Firmenich AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -29.42% vs 20.44% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.14% vs 144.03% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,034.00",
          "val2": "12,799.00",
          "chgp": "-29.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,613.00",
          "val2": "1,848.00",
          "chgp": "-12.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "168.00",
          "val2": "186.00",
          "chgp": "-9.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-51.00",
          "val2": "-96.00",
          "chgp": "46.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "342.00",
          "val2": "280.00",
          "chgp": "22.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "79.00%",
          "val2": "51.70%",
          "chgp": "2.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]